| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004716 | American Journal of Ophthalmology | 2008 | 8 Pages |
Abstract
Intravitreal bevacizumab led to short-term significant visual improvement and regression of inflammatory ocular neovascularization in a wide variety of inflammatory ocular diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ahmad M. Mansour, Friederike Mackensen, J. Fernando Arevalo, Focke Ziemssen, Padmamalini Mahendradas, Abla Mehio-Sibai, Nicholas Hrisomalos, Timothy Y.Y. Lai, David Dodwell, Wai-Man Chan, Thomas Ness, Alay S. Banker, Sivakami A. Pai, Maria H. Berrocal,